American Diabetes Association Releases New Care Standards Focused On Screening, First-Line Therapy & Use Of Technology

New American Diabetes Association (ADA) standards of medical care for 2022 were released on December 20, 2021. The updated standards have significant changes related to screening, first-line therapy, and use of technology compared to the previous standards:

Diabetes screening: Screening for prediabetes and type 2 diabetes should take place regularly starting at age 35, or earlier if other risks are present.
First-line medication therapy: Guidance on first-line therapy should be determined by co-morbidities, such as heart and kidney disease or overweight and obesity.
Pregnancy: Changes to gestational diabetes mellitus (GDM) recommendations regarding when to test and . . .